News Center
Shanghai Pharma awarded Best Industrial Companies of China Pharmaceutical R&D Product Line

Shanghai Pharma has been recently awarded "Best Industrial Companies of China Pharmaceutical R&D Product Line 2017”, and included in the list of Top 100 Enterprises of China Pharmaceutical Industry.

On September 1-4, 2017, China National Pharmaceutical Industry Information Center (PHIIC) held The 34th China Pharmaceutical Industry Information Annual Conference 2017 and Release of Top 100 Pharmaceutical Enterprises of China 2016 in Chengdu.

The list of Best Industrial Companies of China Pharmaceutical R&D Product Line 2017 was released in the conference. The expert panel worked out the list based on long-term research and analysis on objective data of enterprises of the pharmaceutical industry. The enterprises were graded mainly from such perspectives as pharmaceutical innovation, layout, development, competition, status, etc., and from such dimensions as corporate features, leading, duplication, dependence and scale. Shanghai Pharma ranked Top 20 with its outstanding R&D innovation and results.

Shanghai Pharma was once again included in the list of Top 100 Enterprises of China Pharmaceutical Industry this year, ranking the sixth. The key indicator for being included into the list referred to the main business income of the pharmaceutical industry in 2016. The overall scale of the top 100 enterprises this year continued the momentum of rapid growth. The cumulative main business income of the pharmaceutical industry reached 680.9 billion yuan, increasing 11.1% YoY, 1.2% higher than the average level of China's pharmaceutical industry. The lowest threshold to enter the list was further raised to 2.4 billion yuan. And the average size of the Top 100 Enterprises has been expanding at a high speed.

 

The subject of concern
Produced By 大汉网络 大汉版通发布系统